An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011 Jun 01; 186(11):6607-16.